TILVX | VIVIX | TILVX / VIVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 22 years | 26 years | - |
Gain YTD | 16.224 | 16.034 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000000 | 5000000 | 200% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 10.8B | 195B | 6% |
Annual Yield % from dividends | 2.07 | 2.37 | 87% |
Returns for 1 year | 17.60 | 16.43 | 107% |
Returns for 3 years | 15.45 | 20.48 | 75% |
Returns for 5 years | 42.45 | 44.60 | 95% |
Returns for 10 years | 67.93 | 104.87 | 65% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CANC | 25.56 | 0.17 | +0.69% |
Tema Oncology ETF | |||
SCHJ | 24.47 | 0.01 | +0.04% |
Schwab 1-5 Year Corporate Bond ETF | |||
FHLC | 66.41 | -0.09 | -0.14% |
Fidelity MSCI Health Care ETF | |||
VSHY | 21.96 | -0.06 | -0.29% |
Virtus Newfleet Short Dur Hi Yld Bd ETF | |||
DFE | 57.42 | -0.72 | -1.24% |
WisdomTree Europe SmallCap Dividend ETF |